Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort
about
Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patientsLymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis.Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab.The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patientsThe type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseasesBaseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective studyType I interferon in organ-targeted autoimmune and inflammatory diseases.Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.The RNA-binding protein HuR/ELAVL1 regulates IFN-β mRNA abundance and the type I IFN response.Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritisEndothelial cells and fibroblasts amplify the arthritogenic type I IFN response in murine Lyme disease and are major sources of chemokines in Borrelia burgdorferi-infected joint tissue.The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment.Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?Increased baseline RUNX2, caspase 3 and p21 gene expressions in the peripheral blood of disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients are associated with improved clinical response to methotrexate therapy.Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker.Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy.Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis.Prediction of Therapeutic Responses to Tocilizumab in Patients With Rheumatoid Arthritis: Biomarkers Identified by Analysis of Gene Expression in Peripheral Blood Mononuclear Cells Using Genome-Wide DNA Microarray
P2860
Q28290930-F04A844C-1765-499C-BB0B-BFF084EFF506Q34535634-4BABBC32-F37C-4C5A-9068-7C82CD9575B3Q35559143-71586389-633F-43A2-821F-D1B77BF86810Q36245889-36E533E7-81CD-48CC-86B6-20885C397224Q36338717-E01F4742-A590-4F43-9888-09960CCB2F85Q36588160-56CA74CD-2742-4257-B94E-0E285CD0755EQ36825365-4FE7AEDA-A48E-4AFE-AB70-AF1C35AA6717Q37838003-73F47B9D-D947-460F-BD87-3D663B08FF3BQ38335622-63D51BD2-79D9-4A8C-A4BB-5B3960C0E1F9Q41441442-B7821A80-417E-430F-B3B5-55B64C86D4B6Q41632669-D9CC7325-C43E-492C-AADE-B67EAC102C3CQ42108192-F694591F-7BE5-4CB9-A732-53B43A77424AQ42326768-8BE8C2E0-131D-4C29-B4B3-64D359F397B2Q42633541-C7571169-EB87-47FA-AEFA-9A37FE7B2F90Q48030951-F9DC75C1-2F37-4D46-BEC8-35E03096385AQ49539654-B1EA0968-EC50-4A3E-B693-8F1CB0067C89Q51168774-844C590F-9AF4-42BB-8C16-9379A3902AC2Q54346251-5367EBBB-F57D-421D-B928-7F7D4991303DQ58412739-21E4F9AE-8CFE-4307-84CA-90973609C048
P2860
Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Association of the response to ...... predominantly Hispanic cohort
@ast
Association of the response to ...... predominantly Hispanic cohort
@en
Association of the response to ...... predominantly Hispanic cohort
@nl
type
label
Association of the response to ...... predominantly Hispanic cohort
@ast
Association of the response to ...... predominantly Hispanic cohort
@en
Association of the response to ...... predominantly Hispanic cohort
@nl
prefLabel
Association of the response to ...... predominantly Hispanic cohort
@ast
Association of the response to ...... predominantly Hispanic cohort
@en
Association of the response to ...... predominantly Hispanic cohort
@nl
P2093
P2860
P3181
P356
P1476
Association of the response to ...... predominantly Hispanic cohort
@en
P2093
Clio P Mavragani
Mary K Crow
William Stohl
P2860
P304
P3181
P356
10.1002/ART.27226
P407
P577
2010-02-01T00:00:00Z